Viewing Study NCT01322867


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-01-03 @ 4:22 AM
Study NCT ID: NCT01322867
Status: COMPLETED
Last Update Posted: 2021-01-28
First Post: 2011-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bioequivalence study View
None alprazolam View
None frontal View